Cm Management 13F annual report

Cm Management is an investment fund managing more than $109 billion ran by Mark Lilly. There are currently 63 companies in Mr. Lilly’s portfolio. The largest investments include Taseko Mines and Alico, together worth $11.8 billion.

Limited to 30 biggest holdings

$109 billion Assets Under Management (AUM)

As of 25th July 2024, Cm Management’s top holding is 2,450,000 shares of Taseko Mines currently worth over $6 billion and making up 5.5% of the portfolio value. Relative to the number of outstanding shares of Taseko Mines, Cm Management owns more than approximately 0.1% of the company. In addition, the fund holds 225,000 shares of Alico worth $5.83 billion, whose value grew 0.8% in the past six months. The third-largest holding is Amicus Therapeutics Inc worth $4.46 billion and the next is Radiant Logistics worth $4.41 billion, with 775,000 shares owned.

Currently, Cm Management's portfolio is worth at least $109 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Cm Management

The Cm Management office and employees reside in Gulf Breeze, Florida. According to the last 13-F report filed with the SEC, Mark Lilly serves as the Chief Operating Officer at Cm Management.

Recent trades

In the most recent 13F filing, Cm Management revealed that it had opened a new position in CVS Health Corp and bought 30,000 shares worth $1.77 billion. This means they effectively own approximately 0.1% of the company. CVS Health Corp makes up 6.6% of the fund's Health Care sector allocation and has decreased its share price by 18.4% in the past year.

The investment fund also strengthened its position in Alico by buying 10,000 additional shares. This makes their stake in Alico total 225,000 shares worth $5.83 billion. Alico soared 12.1% in the past year.

On the other hand, there are companies that Cm Management is getting rid of from its portfolio. Cm Management closed its position in American Superconductor on 1st August 2024. It sold the previously owned 250,000 shares for $3.38 billion. Mark Lilly also disclosed a decreased stake in Taseko Mines by approximately 0.1%. This leaves the value of the investment at $6 billion and 2,450,000 shares.

One of the smallest hedge funds

The two most similar investment funds to Cm Management are Fmfe Wealth Management and Integrity Advisory. They manage $109 billion and $109 billion respectively.


Mark Lilly investment strategy

Cm Management’s portfolio is diversified across 11 sectors. Currently, their heaviest sector is Health Care — making up 24.7% of the total portfolio value. The fund focuses on investments in the United States as 58.7% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 13% of the total holdings value. On the other hand, small-cap stocks make up only 9.5% of the portfolio. The average market cap of the portfolio companies is close to $15.2 billion.

The complete list of Cm Management trades based on 13F SEC filings

These positions were updated on August 1st based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Taseko Mines Ltd.
2.00%
2,450,000
$6,002,500,000 5.51%
Alico Inc.
4.65%
225,000
$5,829,750,000 5.35%
Amicus Therapeutics Inc
No change
450,000
$4,464,000,000 4.10%
Radiant Logistics, Inc.
6.90%
775,000
$4,409,750,000 4.05%
Royalty Pharma Plc Shs
No change
160,000
$4,219,200,000 3.87%
Newmark Group Inc
No change
400,000
$4,092,000,000 3.75%
Kyndryl Hldgs Inc
No change
140,000
$3,683,400,000 3.38%
American Superconductor Corp.
Closed
250,000
$3,377,500,000
Preformed Line Prods Co
No change
26,000
$3,238,040,000 2.97%
Intest Corp.
37.33%
309,000
$3,052,920,000 2.80%
Rigel Pharmaceuticals
Closed
2,000,000
$2,960,000,000
Arko Corp.
41.67%
1,020,000
$2,913,900,000 2.67%
Pagerduty Inc
No change
120,000
$2,751,600,000 2.52%
Bgc Group Inc
No change
325,000
$2,697,500,000 2.48%
Ark Restaurants Corp.
8.34%
200,000
$2,621,980,000 2.41%
Baidu Inc
100.00%
30,000
$2,594,400,000 2.38%
Organon Co
No change
125,000
$2,587,500,000 2.37%
Talos Energy Inc
60.00%
200,000
$2,430,000,000 2.23%
Alibaba Group Hldg Ltd
50.00%
30,000
$2,160,000,000 1.98%
Viatris Inc.
No change
200,000
$2,126,000,000 1.95%
Barrick Gold Corp.
56.25%
125,000
$2,085,000,000 1.91%
ClearPoint Neuro Inc
No change
375,000
$2,021,250,000 1.85%
Centerra Gold Inc
20.00%
300,000
$2,016,000,000 1.85%
Iovance Biotherapeutics Inc
No change
250,000
$2,005,000,000 1.84%
Coherus Biosciences Inc
10.00%
1,100,000
$1,903,000,000 1.75%
Republic Bancorp Ky
16.67%
35,000
$1,876,350,000 1.72%
Walgreens Boots Alliance Inc
7.14%
150,000
$1,814,250,000 1.66%
CVS Health Corp
Opened
30,000
$1,771,800,000 1.63%
Incyte Corp.
Closed
30,000
$1,709,100,000
Evolus Inc
No change
150,000
$1,627,500,000 1.49%
Sabre Corp
20.00%
600,000
$1,602,000,000 1.47%
Brookline Bancorp, Inc.
5.56%
190,000
$1,586,500,000 1.46%
Service Pptys Tr
No change
300,000
$1,542,000,000 1.41%
First Horizon Natl Corp
Closed
100,000
$1,540,000,000
Pan Amern Silver Corp
25.00%
75,000
$1,491,000,000 1.37%
Warner Bros.Discovery Inc
No change
200,000
$1,488,000,000 1.37%
First Finl Corp Ind
185.71%
40,000
$1,475,200,000 1.35%
Pfizer Inc.
No change
50,000
$1,399,000,000 1.28%
Jazz Pharmaceuticals plc
No change
12,500
$1,334,125,000 1.22%
Xoma Corp Del
No change
55,000
$1,302,950,000 1.20%
Amcon Distrg Co
2.50%
8,200
$1,151,772,000 1.06%
Newell Brands Inc.
No change
175,000
$1,121,750,000 1.03%
Heron Therapeutics Inc
No change
300,000
$1,050,000,000 0.96%
Revance Therapeutics Inc
60.00%
400,000
$1,028,000,000 0.94%
Cohu, Inc.
Opened
30,000
$993,000,000 0.91%
Nektar Therapeutics
20.20%
750,000
$930,000,000 0.85%
Atea Pharmaceuticals, Inc.
No change
270,000
$893,700,000 0.82%
Hasbro, Inc.
Opened
15,000
$877,500,000 0.81%
Curis Inc
No change
120,000
$828,000,000 0.76%
Kraft Heinz Co
Opened
25,000
$805,500,000 0.74%
Park Hotels Resorts Inc
No change
50,000
$749,000,000 0.69%
Tejon Ranch Co.
Closed
45,000
$693,450,000
Acadia Pharmaceuticals Inc
No change
40,000
$650,000,000 0.60%
Coya Therapeutics Inc
No change
100,000
$606,000,000 0.56%
Cytosorbents Corp
3.03%
850,000
$597,550,000 0.55%
Verona Pharma Plc
No change
35,000
$506,100,000 0.46%
Femasys Inc
6.25%
425,000
$484,500,000 0.44%
Battalion Oil Corp
7.69%
140,000
$467,600,000 0.43%
Assertio Holdings, Inc.
1.45%
350,000
$434,000,000 0.40%
Eledon Pharmaceuticals, Inc.
No change
160,000
$422,400,000 0.39%
Bristow Group Inc
Closed
15,377
$418,254,000
Edesa Biotech, Inc.
45.16%
90,000
$385,200,000 0.35%
Lantern Pharma Inc.
23.08%
80,000
$373,600,000 0.34%
Cognition Therapeutics Inc
14.29%
200,000
$332,000,000 0.30%
Compass Therapeutics Inc
No change
310,000
$310,000,000 0.28%
BioCardia, Inc.
Closed
700,000
$284,900,000
Cadence Bank
No change
10,000
$282,800,000 0.26%
Smith Micro Software, Inc.
Closed
600,000
$206,580,000
Elicio Therapeutics Inc
33.33%
50,000
$205,500,000 0.19%
Selecta Biosciences Inc
Closed
305,482
$198,563,000
Kronos Bio, Inc.
46.00%
135,000
$167,400,000 0.15%
Gain Therapeutics Inc
No change
90,000
$115,200,000 0.11%
Pieris Pharmaceuticals Inc
Closed
575,000
$105,340,000
No transactions found
Showing first 500 out of 73 holdings